Log In
BCIQ
Print this Print this
 

KTP-001

  Manage Alerts
Collapse Summary General Information
Company Teijin Pharma Ltd.
DescriptionInjectible formulation of recombinant human matrix metalloproteinase
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard Indication Musculoskeletal (unspecified)
Indication DetailsTreat lumbar disc herniation
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today